Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.85 - $3.21 $451,000 - $782,546
243,784 Added 53.08%
703,071 $1.72 Million
Q4 2022

Feb 13, 2023

SELL
$2.82 - $3.59 $687,470 - $875,184
-243,784 Reduced 34.67%
459,287 $1.52 Million
Q3 2021

Nov 12, 2021

SELL
$15.81 - $28.39 $9,960 - $17,885
-630 Reduced 0.09%
703,071 $11.5 Million
Q2 2021

Aug 16, 2021

BUY
$18.5 - $30.73 $13 Million - $21.6 Million
703,701 New
703,701 $21.6 Million

Others Institutions Holding GRPH

About Graphite Bio, Inc.


  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.